Supernus Pharmaceuticals, Inc. (FRA:S49)

Supernus Pharmaceuticals Revenue

Supernus Pharmaceuticals had revenue of $192.10M USD in the quarter ending September 30, 2025, with 9.34% growth. This brings the company's revenue in the last twelve months to $661.38M, up 1.44% year-over-year. In the year 2024, Supernus Pharmaceuticals had annual revenue of $661.82M with 8.94% growth.

• Revenue (ttm): $661.38M
• Revenue Growth: +1.44%
• P/S Ratio: 3.80
• Revenue / Employee: $981.27K
• Employees: 674
• Market Cap: 2.20B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	661.82M	54.30M	8.94%
Dec 31, 2023	607.52M	-59.72M	-8.95%
Dec 31, 2022	667.24M	87.46M	15.09%
Dec 31, 2021	579.78M	59.38M	11.41%
Dec 31, 2020	520.40M	127.64M	32.50%
Dec 31, 2019	392.76M	-16.14M	-3.95%
Dec 31, 2018	408.90M	106.66M	35.29%
Dec 31, 2017	302.24M	87.24M	40.57%
Dec 31, 2016	215.00M	67.54M	45.80%
Dec 31, 2015	147.47M	54.79M	59.12%
Dec 31, 2014	92.68M	80.66M	671.10%
Dec 31, 2013	12.02M	10.54M	712.09%
Dec 31, 2012	1.48M	677.00K	84.31%
Dec 31, 2011	803.00K	-	-
Dec 31, 2010	-	-	-